100.00% -0.06

Nkgen Biotech Inc (NKGN)

Panoramica Notizia Cronologia dei prezzi Perché NKGN Giù? Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Nkgen Biotech Inc Stock (NKGN) Company Profile

Nkgen Biotech Inc

Healthcare (1114)

Biotechnology (618)

Prossima data di guadagno

Ultimi documenti SEC

NKGN's Discussions on Twitter

Compare NKGN vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NKGN Nkgen Biotech Inc	0.00	0	3,000	-23.55M	-19.75M	-1.2183
VRTX Vertex Pharmaceuticals Inc	499.17	117.08B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	772.03	82.63B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	742.79	45.82B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	322.38	42.92B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	305.39	33.54B	5.36B	287.73M	924.18M	2.5229

Nkgen Biotech Inc Borsa (NKGN) Ultime notizie

Nkgen Biotech Inc Azioni (NKGN) Dati Finanziari

Nkgen Biotech Inc (NKGN)

Nkgen Biotech Inc Stock (NKGN) Company Profile

Compare NKGN vs VRTX, REGN, ARGX, ALNY, ONC

Nkgen Biotech Inc Borsa (NKGN) Ultime notizie

NKGen Biotech Secures Additional Debt Financing from AlpineBrook - TipRanks

Nkgen Biotech amends loan agreement to secure additional $343,000 funding - Investing.com

NKGen Biotech Adds $343,000 via Fourth Amendment to AlpineBrook Secured Note; Principal Now $27.1M - TradingView

NKGen Biotech (NKGN) adds $343,000 under AlpineBrook note - Stock Titan

NKGen Biotech, Inc. and NKGen Operating Biotech, Inc. Enter Amendment to Secured Promissory Note Increases Loan Principal and Funding - marketscreener.com

NKGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

NKGNNKGen Biotech Inc Latest Stock News & Market Updates - Stock Titan

NKGen Biotech increases loan principal by $251,000 under amended agreement By Investing.com - Investing.com Nigeria

NKGen Biotech increases loan principal by $251,000 under amended agreement - Investing.com South Africa

NKGen Biotech expands debt financing with loan amendment - TipRanks

NKGen Biotech Signs Amendment to Secured Promissory Note With AlpineBrook Capital - TradingView

Pre-Market Top Gainer: NKGNW NKGen Warrants NASDAQ $0.0301 Feb 2026: key setup - Meyka

Head to Head Comparison: NKGen Biotech (NYSE:NKGN) versus SQZ Biotechnologies (NYSE:SQZ) - Defense World

NKGen Biotech amends loan agreement and extends forward purchase deal By Investing.com - Investing.com Nigeria

NKGen Biotech amends loan agreement and extends forward purchase deal - Investing.com

NKGen Biotech Secures Additional Funding via Note Amendment - TipRanks

NKGen Biotech Signs Multiple Financing Agreements - TradingView

NKGen Biotech confirms successful acquisition of NKMax - intellectia.ai

NKGen Biotech Appoints Bruce Miller to Scientific Advisory Board - Intellectia AI

NKGen Biotech appoints neurology expert Dr. Bruce Miller to advisory board - Investing.com Nigeria

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board - The Globe and Mail

NKGen Biotech, Inc. SEC 10-Q Report - TradingView — Track All Markets

Nkgen Biotech amends loan agreement to secure additional $295,000 funding - Investing.com India

Nkgen Biotech amends loan agreement to secure additional $295,000 funding By Investing.com - Investing.com South Africa

NKGen Biotech Expands Debt Financing Through Note Amendment - TipRanks

NKGen Biotech Signs Amendment to Secured Promissory Note With AlpineBrook Capital GP I - TradingView — Track All Markets

NKGen Biotech, Inc. and NKGen Operating Biotech, Inc., Enter into an Amendment to Certain Secured Promissory Note with AlpineBrook Capital GP I Limited - marketscreener.com

NKGen Biotech enters $25.8 million secured note agreement with AlpineBrook Capital - Investing.com Australia

NKGen Biotech enters $25.8 million secured note agreement with AlpineBrook Capital By Investing.com - Investing.com South Africa

NKGen Biotech Secures New Promissory Note Financing - TipRanks

NKGen Biotech Signs Secured Promissory Note With AlpineBrook Capital GP I - TradingView

NKGen Biotech issues statement on NKGen Korea board appointments - MSN

Financial Review: Alpha Cognition (OTC:ACOGF) vs. NKGen Biotech (NYSE:NKGN) - Defense World

Analyzing Genocea Biosciences (NASDAQ:GNCA) and NKGen Biotech (NYSE:NKGN) - Defense World

NKGen Biotech, Inc. Issues Statement on Recent Board - GlobeNewswire

Is NKGen Biotech, Inc. technically bullish or bearish? - Markets Mojo

NKGen Biotech announces new funding to regain compliance with reporting obligations and listing standards - MSN

NKMAX CO., Ltd. has Changed its Name to NKGen Korea - marketscreener.com

Sorrento Therapeutics (NASDAQ:SRNE) versus NKGen Biotech (NYSE:NKGN) Head-To-Head Review - Defense World

Sorrento Therapeutics (OTCMKTS:SRNEQ) & NKGen Biotech (NYSE:NKGN) Head-To-Head Review - Defense World

Reviewing NKGen Biotech (NYSE:NKGN) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World

Total debt per share of NKGen Biotech Inc. – OTC:NKGN - TradingView

Revenue per share of NKGen Biotech Inc. – OTC:NKGN - TradingView

NKGen Biotech, Inc. (NKGN) Eps Diluted (Quarterly) - Zacks Investment Research

Nkgen Biotech’s Promising Alzheimer’s Study: A Potential Game-Changer? - TipRanks

Nkgen Biotech Inc Azioni (NKGN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a NKGN